Ascletis’ obesity pill looks similar to Roche’s drug, early data suggest
Ascletis Pharma’s oral GLP-1 allowed patients in an early-stage obesity trial to lose up to 6.3% of their body weight after a month of treatment, the company said Wednesday. A similar ...
Ascletis Pharma’s oral GLP-1 allowed patients in an early-stage obesity trial to lose up to 6.3% of their body weight after a month of treatment, the company said Wednesday.
A similar ...
